Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Study Status entries were added and updated across multiple record versions, reflecting changes in the trial's recruitment and operational status.
    Difference
    0.5%
    Check dated 2026-04-03T18:50:05.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-03-27T12:43:06.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    New version entries (192, 191, 190, 189, 188) were added, including a Study Status update on 2026-03-19. Revision: v3.5.0 was introduced and v3.4.3 was removed.
    Difference
    0.4%
    Check dated 2026-03-20T03:43:23.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Adds several historical versions (183–187) to the Record History, including an update to Study Status on 2026-03-12 and earlier dates. These entries broaden the historical record of the study's updates.
    Difference
    0.4%
    Check dated 2026-03-12T21:36:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-03-05T18:29:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added new entries to the Record History showing a new Document Section and updated Study Status entries. These updates extend the version list up to 2026-02-25.
    Difference
    0.4%
    Check dated 2026-02-26T13:37:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.